Nicole Mahoney is the senior officer for Pew's antibiotics and innovation project, which addresses the growing public health challenge of multidrug-resistant infections by supporting policies that stimulate and encourage the development of antibiotics to treat life-threatening illnesses.
Before joining Pew, Dr. Mahoney served as a U.S. Food and Drug Administration Commissioner’s Fellow in the FDA’s Office of Antimicrobial Products, analyzing the regulatory pathway for all new antibacterial drugs reviewed by the agency between 1980 and 2011. Prior to that, she was a technology development associate at the National Institute for Allergy and Infectious Diseases providing patentability and marketability assessments for new technologies and negotiating agreements for research and the exchange of resources (equipment, funds, reagents) between the institute and partner Organizations. She also served as an American Association for the Advancement of Science policy fellow at both the National Institutes of Health and the National Science Foundation.
Dr. Mahoney earned her PhD in biochemistry from the Albert Einstein College of Medicine and completed postdoctoral training at the University of California, San Francisco.
Following the deadly superbug outbreak in 2011, a recent report published by the NIH indicates new antibiotics could help fight antibiotic resistant bacteria. Senior Officer of Pew's Antibiotics and Innovation Project Nicole Mahoney discusses the new report and the need for a comprehensive strategy to prevent superbug outbreaks.
More info
On August 22, researchers at the National Institute of Health released a scientific paper detailing the use of advanced genetic technology to trace a deadly infection, untreatable by nearly every antibiotic, that spread through the NIH’s Clinical Center last year.
More infoSee All Experts
Copyright(c) 1996-2012 The Pew Charitable Trusts. All Rights Reserved.
[+] Feedback PHG.PRODUCTION.1.20130703.1022 (PEWSUWVMWAPP01)
